clinical trial · NCT05642312
A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema
Hoffmann-La Roche·phase3·completed·n = 245
Uveitic Macular EdemaVamikibartSham
brief summary
This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.
started
Jan 9, 2023
primary completion
Dec 9, 2024
completion
Jul 9, 2025
last updated
Nov 21, 2025
official title
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol